Seattle startup Phase Genomics will develop its platform to detect chromosomal aberrations in cancer with $2.5 million in new funding.
The project is fueled with a $2 million small business award from the U.S. National Cancer Institute and $500,000 in matching funds from Washington state’s Andy Hill CARE Fund.
The state is authorized to match up to $10 million annually to fund cancer research through the fund, launched in memory of state senator Andy Hill, a champion of cancer research. In June 2022, the state legislature authorized an additional $30 million special investment into the fund.
